Lewis A. Chodosh, MD, PhD
Perelman Professor and Chair, Department of Cancer Biology
Abramson Family Cancer Research Institute
Perelman School of Medicine
Identifying the specific pathways and genes responsible for drug resistance and breast cancer recurrence to develop prevention strategies.
Despite advances in detection and treatment, up to 30 percent of patients will experience a breast cancer recurrence with metastatic disease over their lifetimes, sometimes many years after treatment of their primary cancer. Two factors, the presence of residual disease and tumor cell dormancy—a phenomenon whereby tumor cells lay dormant and are undetectable—are likely responsible for many breast cancer recurrences. The mechanisms underlying these processes, however, are largely unknown. Dr. Chodosh is working to identify interventions for breast cancer survivors that can reduce the risk of recurrence and improve long-term outcomes. In his current BCRF research, he is exploring the biological underpinnings of the effects of obesity, weight loss, and exercise on breast cancer recurrence. Dr. Chodosh’s team developed novel laboratory models that recapitulate the effects of obesity, exercise, and caloric restriction on both residual cancer and tumor-cell dormancy. Using these models, they showed that a high-fat diet promoted the survival of disseminated and dormant tumor cells. His team is evaluating the mechanisms involved and hopes their findings will enable the design of behavioral and therapeutic interventions with the potential to prevent tumor recurrence and reduce the mortality associated with metastatic breast cancer.
Using his novel experimental models, Dr. Chodosh’s team has identified five classes of genes that may play a functional role in tumor cell dormancy and breast cancer recurrence. Other studies comparing the genomic data from patient-matched primary and recurrent metastatic breast cancers revealed that five genes were mutated in the metastases but not in the primary cancers. In the last year, Dr. Chodosh’s team developed a breast cancer model demonstrating that obesity can accelerate tumor recurrence and also found that these effects can be reversed by weight loss.
Dr. Chodosh and his team will test the role of the candidate genes that they identified in tumor dormancy and recurrence. They will also investigate the role of the candidate genes in the development of resistance to therapy and will continue experiments to determine the molecular and cellular basis for the impact of obesity on breast cancer recurrence. Improving our understanding of tumor dormancy and recurrence and developing therapies that specifically target dormant residual cancer cells is a critical step toward reducing breast cancer mortality.
Dr. Lewis A. Chodosh is a physician-scientist who received a BS in Molecular Biophysics and Biochemistry from Yale University, and MD from Harvard Medical School, and a PhD. in Biochemistry from M.I.T. in the laboratory of Dr. Phillip Sharp. He performed his clinical training in Internal Medicine and Endocrinology at the Massachusetts General Hospital, after which he was a postdoctoral research fellow with Dr. Philip Leder at Harvard Medical School. Dr. Chodosh joined the faculty of the University of Pennsylvania in 1994, where he is currently a Professor in the Departments of Cancer Biology, Cell & Developmental Biology, and Medicine. Dr. Chodosh serves as Chairman of the Department of Cancer Biology, Associate Director for Basic Science of the Abramson Cancer Center, and Director of Tumor Biology for the Abramson Family Cancer Research Institute at the University of Pennsylvania. Dr. Chodosh also serves as Editor-in-Chief of Breast Cancer. His research focuses on genetic, genomic and molecular approaches to understanding breast cancer susceptibility and pathogenesis.
The William P. Lauder Award
When you give to BCRF, you're funding critical hours in the lab. More time for research means longer, healthier lives for the ones we love.